Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes

Malika Kapadia; Leslie Lehmann; Jeffery Auletta; Lisa Beatty; Neel Bhatt; Robyn Blacken; Kathy Demmel; Therese Dodd; Catherine Desmond; Taylor Fitch; Laura Flesch; David Hartley; John Huber; Hannah Ingraham; Rita Jakubowski; Anna Klunk; Christa Krupski; Katilyn Kusnier; Nicole Liberio; Joseph Maakaron; Mark Mueller; Kasiani C. Myers; Ahna Pai; Loretta Parker; Sagar Patel; Rachel Phelan; Veronika Polishchuk; Audrey Sigmund; Christine Sper; Sarah Tarquini; Mark Juckett; Samantha Jaglowski; Christopher Dandoy; Seth Rotz

doi:10.1016/j.jtct.2022.02.003

Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes

Malika Kapadia, Leslie Lehmann, Jeffery Auletta, Lisa Beatty, Neel Bhatt, Robyn Blacken, Kathy Demmel, Therese Dodd, Catherine Desmond, Taylor Fitch, Laura Flesch, David Hartley, John Huber, Hannah Ingraham, Rita Jakubowski, Anna Klunk, Christa Krupski, Katilyn Kusnier, Nicole Liberio, Joseph MaakaronMark Mueller, Kasiani C. Myers, Ahna Pai, Loretta Parker, Sagar Patel, Rachel Phelan, Veronika Polishchuk, Audrey Sigmund, Christine Sper, Sarah Tarquini, Mark Juckett, Samantha Jaglowski, Christopher Dandoy, Seth Rotz

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.

Original language	English (US)
Pages (from-to)	233-241
Number of pages	9
Journal	Transplantation and Cellular Therapy
Volume	28
Issue number	5
DOIs	https://doi.org/10.1016/j.jtct.2022.02.003
State	Published - May 2022

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Molecular Medicine
Hematology
Cell Biology
Transplantation

Access to Document

10.1016/j.jtct.2022.02.003

Cite this

Kapadia, M., Lehmann, L., Auletta, J., Beatty, L., Bhatt, N., Blacken, R., Demmel, K., Dodd, T., Desmond, C., Fitch, T., Flesch, L., Hartley, D., Huber, J., Ingraham, H., Jakubowski, R., Klunk, A., Krupski, C., Kusnier, K., Liberio, N., ... Rotz, S. (2022). Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplantation and Cellular Therapy, 28(5), 233-241. https://doi.org/10.1016/j.jtct.2022.02.003

@article{6452a22e77cc4b98b534ad524242ddd6,

title = "Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes",

abstract = "Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.",

author = "Malika Kapadia and Leslie Lehmann and Jeffery Auletta and Lisa Beatty and Neel Bhatt and Robyn Blacken and Kathy Demmel and Therese Dodd and Catherine Desmond and Taylor Fitch and Laura Flesch and David Hartley and John Huber and Hannah Ingraham and Rita Jakubowski and Anna Klunk and Christa Krupski and Katilyn Kusnier and Nicole Liberio and Joseph Maakaron and Mark Mueller and Myers, {Kasiani C.} and Ahna Pai and Loretta Parker and Sagar Patel and Rachel Phelan and Veronika Polishchuk and Audrey Sigmund and Christine Sper and Sarah Tarquini and Mark Juckett and Samantha Jaglowski and Christopher Dandoy and Seth Rotz",

note = "Publisher Copyright: {\textcopyright} 2022 The American Society for Transplantation and Cellular Therapy",

year = "2022",

month = may,

doi = "10.1016/j.jtct.2022.02.003",

language = "English (US)",

volume = "28",

pages = "233--241",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6367",

publisher = "Elsevier BV",

number = "5",

}

Kapadia, M, Lehmann, L, Auletta, J, Beatty, L, Bhatt, N, Blacken, R, Demmel, K, Dodd, T, Desmond, C, Fitch, T, Flesch, L, Hartley, D, Huber, J, Ingraham, H, Jakubowski, R, Klunk, A, Krupski, C, Kusnier, K, Liberio, N, Maakaron, J, Mueller, M, Myers, KC, Pai, A, Parker, L, Patel, S, Phelan, R, Polishchuk, V, Sigmund, A, Sper, C, Tarquini, S, Juckett, M, Jaglowski, S, Dandoy, C & Rotz, S 2022, 'Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes', Transplantation and Cellular Therapy, vol. 28, no. 5, pp. 233-241. https://doi.org/10.1016/j.jtct.2022.02.003

TY - JOUR

T1 - Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy

T2 - Using the Model for Improvement to impact Outcomes

AU - Kapadia, Malika

AU - Lehmann, Leslie

AU - Auletta, Jeffery

AU - Beatty, Lisa

AU - Bhatt, Neel

AU - Blacken, Robyn

AU - Demmel, Kathy

AU - Dodd, Therese

AU - Desmond, Catherine

AU - Fitch, Taylor

AU - Flesch, Laura

AU - Hartley, David

AU - Huber, John

AU - Ingraham, Hannah

AU - Jakubowski, Rita

AU - Klunk, Anna

AU - Krupski, Christa

AU - Kusnier, Katilyn

AU - Liberio, Nicole

AU - Maakaron, Joseph

AU - Mueller, Mark

AU - Myers, Kasiani C.

AU - Pai, Ahna

AU - Parker, Loretta

AU - Patel, Sagar

AU - Phelan, Rachel

AU - Polishchuk, Veronika

AU - Sigmund, Audrey

AU - Sper, Christine

AU - Tarquini, Sarah

AU - Juckett, Mark

AU - Jaglowski, Samantha

AU - Dandoy, Christopher

AU - Rotz, Seth

PY - 2022/5

Y1 - 2022/5

N2 - Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.

AB - Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.

UR - http://www.scopus.com/inward/record.url?scp=85126771134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126771134&partnerID=8YFLogxK

U2 - 10.1016/j.jtct.2022.02.003

DO - 10.1016/j.jtct.2022.02.003

M3 - Review article

C2 - 35151937

AN - SCOPUS:85126771134

SN - 2666-6367

VL - 28

SP - 233

EP - 241

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 5

ER -

Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this